Report Demonstrates Stevenage Bioscience Catalyst’s Key Role in Delivering the Economic Benefit From Leading Edge UK Life Sciences
An independent report has been released today by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK.
- An independent report has been released today by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK.
- SBC was formed through a collaboration between the UK Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.
- Entitled Stevenage Bioscience Catalysts key role in delivering economic benefit from life sciences, the report finds that SBC has supported not only early innovation but also scale-up businesses across the life sciences value chain, delivering an outstanding contribution to the UK economy.
- Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.